Stephan Moll, MD writes… The annual meeting of the American Society of Hematology (ASH) took place this month (Dec 6-12th, 2013) in New Orleans. Relatively few new data about blood clots and blood thinners that have an impact on clinical management were presented. I found no practice-changing abstract. The clinically relevant highlights, summarized for health care professionals, are discussed here.
Disclosure: I have been a consultant for Boehringer-Ingelheim, Daiichi, Janssen, and CSL Behring.
Last Updated: Dec 31st, 2013